Osimertinib: Toxic epidermal necrolysis: case report.

On day 32 after treatment initiation, she developed erythematous papules on the anterior chest wall. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event An 80-year-old woman developed toxic epidermal necrolysis (TEN) during treatment with osimertinib for adenocarcinoma stage-VIB. Five days after treatment discontinuation, she started treatment with oral prednisolone. [Extracted from the article]